HIV Innovations for Improved Patient Outcomes for Priority Populations Program
Page 2

1) The development of plans and innovations associated with capacity building and support for scale-up of efficient and effective approaches and models that are designed for HIV-related services.

2) The promise to support the South Africa Government in the process of creating, developing, implementing, and institutionalizing innovations and technological advances that would substantially improve patient outcomes for certain key populations who are affected with HIV.

Primarily, the participating organization will be tasked to support the South African Government in determining, strengthening, and institutionalizing better and cost-effective practices and innovations that would help in the diagnosis, management, and treatment of HIV and AIDS.

All the innovations and technological/medical advances that will be covered under the program should all be in accordance with policies and priorities that are set by the South African government.

The United States Agency for International Development is set to administer a total funding amount of $105,000,000 to support the HIV Innovations for Improved Patient Outcomes for Priority Populations Program.

The local organizations and institutions that will be deemed eligible to submit an application under this program are the following:

1) Any local South African partner

2) Non-governmental organizations and institutions

3) Private voluntary organizations (PVOs)

4) Faith-based and community organizations

5) For-profit and non-profit establishments including small businesses.

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on children grants and education grant money.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Health Resources and Services Administration: HIV Care Grant Program, Part B
Part B of the HIV Care Grant Program is designed to develop or improve the people's access to a comprehensive continuum of high-quality, community-based care for low-income patients diagnosed with HIV.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program.

---